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Tumor necrosis factor (TNF) alpha is a cytokine capable of inducing caspase-dependent (apoptotic) cell
death in some cells and caspase-independent (necrosis-like) cell death in others. Here, using a mutagenesis
screen for genes critical in TNF-induced death in L929 cells, we have found that H-ferritin deficiency is
responsible for TNF resistance in a mutant line and that, upon treatment with TNF, this line fails to elevate
levels of labile iron pool (LIP), critical for TNF-induced reactive oxygen species (ROS) production and
ROS-dependent cell death. Since we found that TNF-induced LIP in L929 cells is primarily furnished by
intracellular storage iron, the lesser induction of LIP in H-ferritin-deficient cells results from a reduction of
intracellular iron storage caused by less H-ferritin. Different from some other cell lines, the H-ferritin gene in
L929 cells is not TNF inducible; however, when H-ferritin is expressed in L929 cells under a TNF-inducible
system, the TNF-induced LIP and subsequent ROS production and cell death were all prevented. Thus, LIP is
a common denominator of ferritin both in the enhancement of cell death by basal steady-state H-ferritin and
in protection against cell death by induced H-ferritin, thereby acting as a key determinant of TNF-induced cell
death.
Tumor necrosis factor (TNF) alpha is a cytokine originally
identified as a factor that led to the hemorrhagic necrosis of an
established tumor (9, 38) and has since been shown to play a
crucial role in the pathogenesis of acute and chronic inflam-
matory diseases (3, 4, 36). TNF can induce apoptotic (caspase-
dependent) or necrotic (caspase-independent) cell death in
vitro, depending on the nature of the cell line used (5, 16, 52,
53). Although TNF-induced apoptosis may participate in in-
flammatory responses, TNF-induced necrosis seems to also
have a stronge pathophysiological effect, as evidenced by the
increased toxicity of TNF in vivo when the pan-caspase inhib-
itor zVAD, which inhibits apoptosis but enhances necrosis, is
applied (10).
Both apoptosis and necrosis are initiated by TNF receptor 1
(TNFR1) clustering and TNFR1-associated death domain
(TRADD) recruitment (6, 8, 19, 33, 47). The TNFR1-associ-
ated death domain subsequently recruits other effectors, such
as the Fas-associated death domain, which is required for
caspase-8 autoactivation in the apoptosis pathway. The necro-
sis pathway may diverge somewhere downstream of these ef-
fectors since known proapoptotic caspases, or cytochrome c
release, are not involved in this death pathway (16, 17, 51, 56,
57). Furthermore, receptor interacting protein (RIP) in the
TNFR1 complex is required for caspase-independent death
and has been suggested to be involved in necrosis (23, 35).
Despite the differences in TNF-induced apoptosis and necro-
sis, mitochondria play a role in both types of cell death (7, 18,
48). Reactive oxygen species (ROS) are known to be involved
in both TNF-induced apoptosis and necrosis (18).
Iron is utilized as a catalyst at the active site of numerous
enzymes involved in oxygen metabolism and electron transport
and is thus a key element of redox reactions (26). The largest
percentage of intracellular iron is tightly bound to different
proteins as a cofactor or for storage. Only a small portion
(0.2 to 3%) of cellular iron is “iron in transit,” termed the
labile iron pool (LIP) (14, 26). LIP constitutes chelatable and
redox-active iron and serves as a crossroad of cell iron metab-
olism. LIP is able to promote the formation of ROS since LIP
and ROS levels have been shown to follow similar “rise and
fall” patterns (32). Elevated levels of LIP are commonly as-
sumed to compromise cell integrity by ROS. Regulatory mech-
anisms, such as expression of the iron supplier transferrin re-
ceptor and iron-withdrawing protein ferritin, have been
implied in maintaining LIP at relatively low levels (1, 46).
Ferritin is the major intracellular iron storage protein, consist-
ing of 24 subunits of heavy (H) and light (L) polypeptide chains
with varying H/L ratios ranging from H24L0 to H0L24, and
controls the level of LIP by accommodating the excess iron
(14). Conversely, the ferritin-bound storage iron is released
when LIP is low in order to make iron available for cellular
functions (26). This concept is supported by experimental ev-
idence showing that the overexpression of H-ferritin reduces
steady-state LIP levels and ensuing ROS production (14),
whereas the inhibition of H-ferritin expression evokes an in-
crease in the levels and pro-oxidant activity of LIP (27, 28, 44).
Iron-regulated ferritin expression through the iron regulatory
protein–iron-responsive element system has been well studied
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(40, 54) and is believed to be a mechanism that controls LIP
levels. H-ferritin is also a stress- or inflammation-regulated
protein since H-ferritin transcription can be regulated by cy-
tokines, such as TNF, in some cells (12, 37). Alternation of iron
metabolism is part of the cellular response to TNF and is
involved in TNF-induced cellular events such as NF-B acti-
vation (60). Ferritin expression is generally considered a means
of protection against oxidative damage since the induction of
ferritin by iron results in a resistance to various types of oxi-
dative stimuli (2, 44, 50). H-ferritin-mediated resistance to
TNF-induced apoptosis in HeLa and other cells has also been
reported (12, 41).
L929 is murine fibroblast cell line primarily used in TNF
bioassay. TNF treatment of L929 cells leads to a caspase-
independent cell death with necrotic phenotype (16). In order
to further address the less well-defined mechanism of TNF-
induced caspase-independent cell death, we have used a ran-
dom gene disruption approach to generate a series of L929
mutant lines resistant to TNF-induced cell death, a technique
that has proven to be an excellent approach for the identifica-
tion of genes involved in TNF-induced cell death (34, 39, 58).
The gene disrupted in one of the TNF-resistant lines was
identified as H-ferritin. We observed that in the H-ferritin-
deficient (Fermut) cells, the basal levels of total cellular iron
and LIP are lower and higher, respectively, than those in wild-
type L929 cells. We also found that TNF induces a substantial
increase of LIP followed by an extensive increase of ROS
generation in wild-type L929 cells. Interestingly, although
Fermut cells had higher basal steady-state LIP levels, less LIP
induction after TNF stimulation was observed in these cells.
This can be explained by our observation that the intracellular
iron storage is the major source to furnish the induced LIP.
Importantly, ROS production after TNF treatment, which mir-
rors LIP induction, also exhibits an impaired induction in
Fermut cells. Because ROS production is required for TNF-
induced L929 cell death (18, 49), the impaired ROS response
accounts for, at least in part, the resistance to TNF-induced
cell death in Fermut cells. In contrast to some other cell lines
(12, 37), L929 cells are not inducible for H-ferritin expression
after TNF treatment (59). We show by ectopically expressing
H-ferritin under a TNF-inducible promoter that TNF-induc-
ible expression of H-ferritin prevents a TNF-induced increase
of LIP and ROS as well as cell death in L929 cells. Thus, LIP
can be modulated by multiple mechanisms and LIP level is a
central determinant of ROS production and cell death in TNF-
treated cells.
MATERIALS AND METHODS
Mutagenesis and identification of mutated gene. The pDisrup retroviral vector
was used to randomly disrupt genes in L929 cells as described in our previous
publications (34, 39, 58). The type of parental L929 cell used in the mutagenesis
is a selected subclone which exhibited a spontaneous survival rate (regrowth) of
less than 1 in 106 after 48 h of exposure to TNF at 100 ng/ml. The identity of the
gene of the viral vector insertion site was determined by 3 rapid amplification of
cDNA ends (RACE) and DNA sequencing of the 3 RACE product as we
described previously (58).
Plasmids and cell transfection. cDNA of H-ferritin was subcloned into
pcDNA6 (Invitrogen) vector or B151 vector (a gift from V. Kravchenko, The
Scripps Research Institute) for reconstitution and inducible expression by TNF,
respectively. The calcium phosphate method was used for transfection. Stably
transfected clones were selected in normal growth medium with the addition of
blasticidin S (10 g/ml; Invitrogen).
Measurement of cell death. Cells were trypsinized, collected by centrifugation,
washed once with phosphate-buffered saline (PBS), and resuspended in PBS
containing 1 g/ml propidium iodide (PI). The levels of PI incorporation were
quantified by flow cytometry on a FACScan flow cytometer (Beckman Coulter
EPICS XL).
Measurement of mRNA levels. Semiquantitative PCR was performed using the
Relative reverse transcription (RT)-PCR kit (Ambion, Austin, TX) following the
manufacturer’s instruction. For real-time PCR analysis, 0.5 g of total RNA
from L929 or A549 cells was used to prepare cDNA by using the Omniscript RT
kit (QIAGEN) with oligo(dT)12 as a primer. The SYBR green PCR Master Mix
kit (Applied Biosystems) was used in the real-time PCR analysis.
Measurement of total cellular iron. The total cellular iron was measure as
described by Epsztejn et al. (14). Triplicate samples of 5  106 cells suspended
in 1 ml of an HBS buffer (20 mM HEPES [pH 7.5], 150 mM NaCl) were mixed
with an equal volume of an acid mixture (3 N HCl, 10% trichloroacetic acid, 3%
thioglycolic acid) and incubated for 2 h at 37°C, cooled, centrifuged at 3,000 rpm
for 30 min, and mixed with 0.5 ml batophenan troline sulconate (0.045% in 4.5
N Na acetate–0.2% thioglycolic acid), and the light absorption of the pink
solution was read at 535 nm in a UV-VIS photodiode spectrophotometer.
Measurement of relative LIP level. The LIP levels were measure as described
by Epsztejn et al. (15). Because TNF treatment leads to loss of cell viability, we
washed away dead cells before the measurement and normalized fluorescence
reading with the number of viable cells based on a standard curve of fluorescence
intensity cell number. Briefly, the cells were cultured in a 96-well assay plate
(white plate with clear bottom, Corning Inc., Corning, NY) and treated with TNF
(100 ng/ml) for different periods of time and then loaded with calcein (CA)
acetoxymethyl ester (CA-AM; Molecular Probes, Eugene, OR) by changing the
medium with or without TNF and with freshly prepared medium containing 0.5
M CA-AM. The cells were further cultured for 30 min and then washed twice
with HBS (20 mM HEPES [pH 7.3], 150 mM NaCl, 20 M CaCl2, 10 mM
glucose) and maintained in HBS. Fluorescence was measured at an excitation of
488 nm and emission of 517 nm using an LS55 luminescence spectrometer
(PerkinElmer, Norwalk, CT) equipped with a plate reader accessory. The cells
were then treated with 0.1 mM iron chelator salicylaldehyde isonicotinoyl hy-
drazone (42) for 10 min. The fluorescence of CA in these cells was measured
again. The number of cells was then measured by crystal violet assay and used to
normalize the fluorescence reading. A standard curve for fluorescence intensity
and cell number was drawn by plating different numbers of cells in a 96-well plate
and loading them with CA-AM as described above. The F of the measurement
normalized two times was obtained, and the relative LIP of each sample was
calculated by dividing its F with the F obtained from wild-type cells in resting
stage.
Measurements of ROS. Generation of intracellular superoxides were deter-
mined according to the fluorescence of ethidium as a result of the oxidation of
hydroethidine (also known as dihydroethidium [HE]; Molecular Probes). HE at
10 g/l in dimethyl sulfoxide (DMSO) was stored in nitrogen at 80°C. HE (16
M) or a DMSO vehicle was added to cells at the same time and incubation took
place for 15 min at 37°C. Fluorescence was measured by flow cytometry. Dichlo-
rofluorescin-diacetate (DCFH-DA; Molecular Probes) fluoresces upon oxidation
by hydrogen peroxide. DCFH-DA was stored at 4 mM in DMSO at 80°C. Cells
were trypsinized, collected by centrifugation, washed once with PBS, and resus-
pended in PBS. DCFH-DA (20 M) or a DMSO vehicle was added to cells at the
same time. Thirty minutes later, fluorescence was measure by flow cytometry on
a FACScan flow cytometer.
Gel shift assay. Nuclear extracts were prepared from cultured cells, and gel
shifts using these nuclear extracts were carried out as previously described (31).
RESULTS
Disruption of the H-ferritin gene in L929 cells confers re-
sistance to TNF-induced cell death. We used retrovirus inser-
tion-mediated mutagenesis in L929 cells coupled with TNF
treatment to select TNF-resistant cell lines generated by the
viral insertion. As described in our previous reports (34, 39,
58), the retroviral vector was designed so that the neo gene is
fused to the sequence of the exon located at the 3 end of the
viral insertion site. The identities of the disrupted genes in the
various TNF-resistant cell lines were determined by 3 RACE
of the fused neo mRNA.
The gene disrupted in one of the TNF-resistant cell lines was
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identified as H-ferritin. A partial sequence of the fused gene
product generated by retroviral insertion in this line (termed
Fermut) is shown in Fig. 1a. The neo gene encoded by the viral
vector was inserted into the H-ferritin coding region disrupting
an H-ferritin gene. Semiquantitative PCR analysis revealed a
reduced expression of H-ferritin mRNA (Fig. 1b), confirming
that one allele of the H-ferritin gene had been disrupted.
Fermut cells showed significant resistance to TNF-induced kill-
ing at low or high TNF concentrations (Fig. 1c).
To establish whether the TNF resistance of Fermut cells is
due to a decrease in H-ferritin expression, we stably trans-
fected the expression vector of H-ferritin under the control of
a cytomegalovirus promoter or empty vector into the Fermut
cell line (designated Ferritin-Fermut and Vector-Fermut, re-
spectively). The reconstitution of H-ferritin expression was
determined by semiquantitative PCR and is shown in Fig. 1d.
The expression of H-ferritin in Fermut cells reconstituted sen-
sitivity to TNF-induced cell death, while vector transfection of
Fermut cells had no effect on TNF sensitivity (Fig. 1e). Thus,
the resistance to TNF-induced cell death observed in the
Fermut cell line is due to the reduced level of H-ferritin ex-
pression.
In parallel, we also determined whether the ferroxidase ac-
tivity of H-ferritin is required for the reconstitution of TNF
sensitivity in Fermut cells. We expressed in Fermut cells a H-
ferritin mutant defective in ferroxidase activity (11) in which
E62 and H65 were mutated to K and G, respectively (termed
E62K/H65G). Expression of E62K/H65G did not reconstitute
the sensitivity to TNF-induced cell death in Fermut cells (Fig.
1f), indicating that the ferroxidase activity of H-ferritin is re-
quired for its function in TNF-induced cell death in L929 cells,
consistent with its role of converting “free iron” to storage
iron.
The resistance of Fermut cells is selective to TNF-induced
cell death. To determine whether the resistance to cell death
by H-ferritin deficiency is selective, we examined the sensitivity
of Fermut cells to several death stimuli. As shown in Fig. 2,
Fermut cells were resistant to TNF-induced cell death but more
sensitive to H2O2-induced cell death. The increased sensitivity
to H2O2 in Fer
mut cells is consistent with previous observations
that higher H-ferritin levels confer greater resistance to H2O2-
induced cell death (14). The sensitivity of Fermut to UV irra-
diation-, mitomycin-, 5-fluorouracil-, or vincristine-induced
cell death was comparable to that observed in the wild-type
L929 cells. Thus, H-ferritin-deficiency-mediated TNF resis-
tance is not due to a general promotion of cell survival but is
caused by an impairment of the death pathway used by TNF.
Since inhibition of caspases by the pan-caspase inhibitor
zVAD can enhance necrotic cell death in L929 cells (57), we
examined whether the mutation of H-ferritin alters zVAD’s
effect on TNF-induced cell death in L929 cells. As shown in
FIG. 1. H-ferritin mutation leads to a resistance to TNF-induced cell death in L929 cells. (a) The fused mRNA of neo and an endogenous gene
in a TNF-resistant L929 clonal cell line was amplified by 3 RACE. The junction sequence of the fused cDNA is shown, which reveals that the viral
insertion occurred at the coding region of the H-ferritin gene. Amino acid sequence at the C terminus of neo is shown beneath the cDNA sequence.
The sequence introduced by the viral vector is shown in lowercase. The number in parentheses indicates the position relative to the start codon
of ferritin. (b) H-ferritin mRNA is reduced in H-ferritin mutant cells (Fermut). A semiquantitative RT-PCR was performed using the total RNA
from wild-type parental (Wt) and Fermut cells, and an ethidium bromide stain is shown. (c) Wild-type and Fermut cells were treated with different
concentrations of TNF as indicated. The cells were harvested 48 h after the treatment, and cell viability was assessed by PI exclusion. (d) Stable
cell lines were generated from Fermut cells by transfection of H-ferritin expression vector (Ferritin-Fermut) or empty vector (Vector-Fermut). The
H-ferritin mRNA levels were examined by semiquantitative PCR. GADPH, glyceraldehyde-3-phosphate dehydrogenase. (e) The cells described
for panel d were treated with TNF (40 ng/ml) for different periods of time. Cell viability was assessed by PI exclusion. (f) Stable cell lines were
generated from Fermut cells by transfection of an expression vector for an H-ferritin mutant with an inactive ferroxidase center (E62K/H65G-
Fermut). The sensitivity to TNF-induced cell death was measured as described for panel e.
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Fig. 2b, caspase inhibition by zVAD equally enhanced TNF-
induced cell death in wild-type and Fermut L929 cells.
H-ferritin deficiency alters the levels of total cellular iron
and LIP in Fermut cells. Since H-ferritin plays a central role in
regulating cellular iron availability, we measured total iron in
Fermut as well as wild-type L929 cells. The total iron was 25%
lower in Fermut cells than in wild-type L929 cells (Fig. 3a).
Expression of H-ferritin, but not the E62K/H65G mutant or
empty vector, in Fermut cells increased total iron to a level
similar to that in wild-type L929 cells (Fig. 3a). These results
indicate that lower expression of H-ferritin in Fermut cells leads
to less storage of iron and is consistent with the iron storage
function of ferritin.
In contrast to the total iron concentration, Fermut cells had
30% more LIP than wild-type L929 cells (Fig. 3b). The level
of LIP is regulated by H-ferritin expression, since reconstituted
Fermut cells (Ferritin-Fermut) had levels of LIP similar to those
in wild-type L929 cells (Fig. 3b), and is in accordance with
previous reports that cellular levels of H-ferritin are correlated
with LIP levels.
LIP induction correlates with ROS production and cell
death. It has been shown that TNF induces ROS production
and that ROS induction is required for TNF-induced death in
L929 cells. We measured oxidative burst and peroxidase activ-
ity with HE and DCFH-DA. Fermut cells have higher basal
ROS levels than wild-type L929 cells (Fig. 4a, top panels). This
is most likely caused by the higher basal LIP concentrations in
Fermut cells (Fig. 3b), further explaining why Fermut cells are
more sensitive to H2O2-induced cell death (Fig. 2). Moreover,
as reported previously (18), TNF treatment led to an increase
in the ROS level in L929 cells (Fig. 4a). Interestingly, although
Fermut cells have a higher basal ROS level, these cells showed
much less ROS induction by TNF than wild-type cells (Fig. 4a).
In other words, ROS levels in TNF-treated Fermut cells were
lower than those in TNF-treated wild-type cells. As aforemen-
tioned, ROS production is required for TNF-induced cell
death in L929 cells and the resistance to TNF-induced cell
death in Fermut cells is, at least in part, caused by an impaired
ability to produce ROS in response to TNF treatment.
Since LIP is involved in ROS production, we questioned why
Fermut cells have higher steady-state levels of LIP before TNF
treatment and yet produce less ROS after TNF stimulation. To
address this question, we measured LIP during the course of
TNF treatment. As shown in Fig. 4b, TNF stimulation signif-
icantly increased LIP in the wild-type L929 cells. Although
Fermut cells have higher initial LIP levels, the induction of LIP
by TNF was modest and the LIP levels in Fermut cells were
actually significantly lower than that in wild-type cells after
treatment. These results are consistent with the observation by
many others that LIP and ROS levels follow similar rise and
fall patterns (26, 32) and suggest that reduced ROS induction
in TNF-treated Fermut cells is most likely due to impaired LIP
induction.
To confirm that TNF-induced ROS production is dependent
on LIP induction, we treated the cells with iron chelator de-
feroxamine. Deferoxamine was able to inhibit TNF-induced
ROS production in L929 cells (Fig. 4c). To further determine
whether LIP indeed plays a role in TNF-induced ROS-depen-
FIG. 2. Fermut cells are selectively resistant to TNF-induced death
and have similar sensitivity to zVAD-enhanced cell death in compar-
ison to wild-type L929 cells. (a) Wild-type (Wt) and Fermut cells were
treated with different concentrations of TNF, H2O2, mytomycin, 5-flu-
orouracil, and vincristine for 48, 9, 96, 65, and 96 h, respectively, or
with different doses of UV light. Cell viability was measured as de-
scribed above. (b) Wild-type and Fermut cells were treated with TNF
(100 ng/ml) and/or zVAD (1 M or 10 M) in different combinations
for 24 h. Cell viabilities were measured.
FIG. 3. Lower level of H-ferritin in Fermut cells results in low total
cellular iron and high basal LIP levels compared with levels in wild-
type cells (Wt). (a) Total cellular iron in wild-type, Fermut, and recon-
stituted lines was measured. H-ferritin deficiency results in reduced
total cellular iron. (b) LIP levels in wild-type, Fermut, and reconstituted
lines were measured. The results indicate that H-ferritin mutation
leads to an increase in the steady level of LIP.
6676 XIE ET AL. MOL. CELL. BIOL.
dent L929 cell death, we measured cell viability in a parallel
experiment. Deferoxamine was able to protect against TNF
cytotoxicity in L929 cells (Fig. 4d). The survival rates of Fermut
and wild-type cells were about the same in the presence of
	200 M of deferoxamine, confirming that H-ferritin defi-
ciency in Fermut alters the chelatable iron pool to influence
TNF-induced cell death. These results again demonstrate that
LIP induction is required for the ROS generation and cell
death of TNF-treated L929 cells.
Low intracellular iron storage in Fermut cells limits LIP
induction by TNF. We next explored why Fermut cells have an
impaired LIP response to TNF stimulation. It is known that
there exist two major physiological mechanisms that furnish
iron to the LIP: iron uptake from outside the cell and iron
release from intracellular ferritin (26, 43). Because H-ferritin
deficiency in Fermut leads to a reduced storage of iron as
assayed for the total iron level (Fig. 3a) and much less LIP
induction after TNF treatment in the same cells (Fig. 4b), we
hypothesized that the ferritin-bound storage of iron is a major
source of iron for furnishing TNF-induced LIP in L929 cells
and that reduced iron storage pools result in a corresponding
decrease in LIP induction in TNF-treated Fermut cells.
To test this hypothesis, we evaluated whether the uptake of
exogenous iron is involved in TNF-induced LIP and cell death.
Iron-free medium has been used by other investigators (55) to
exclude the involvement of exogenous iron, and the same strat-
egy was employed here to determine the role of exogenous
iron. Serum-free medium containing iron [0.1 mg/liter
FIG. 4. TNF-induced ROS production and LIP elevation are impaired in Fermut cells, and the LIP induction is required for TNF-induced ROS
production and cell death. (a) Wild-type (Wt) and Fermut cells were treated with TNF (40 ng/ml). ROS production was measured at different times
of the treatment with HE and DCFH-DA, respectively. Fermut cells have much less ROS induction by TNF in comparison with wild-type L929 cells.
(b) Wild-type and Fermut cells were treated with TNF. LIP levels were measured at different times of the treatment. Fermut cells have much less
LIP induction by TNF in comparison with wild-type L929 cells. (c) Wild-type and Fermut cells were pretreated with the indicated concentrations
of deferoxamine for 6 h, followed by additional 24-h TNF treatment. The ROS levels were measured by HE staining. (d) Wild-type and Fermut
cells were pretreated with the indicated concentrations of deferoxamine for 6 h, followed by 24-h TNF treatment. The survival rates were
determined by PI exclusion.
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Fe(NO3)3–5 g/ml iron-saturated transferrin, termed normal]
and the same medium without iron and transferrin (iron free)
were separately used to determine the effects of iron uptake on
TNF-induced L929 cell death. Both the serum-free and iron
deprivation conditions did not have significant effects on the
viability of L929 cells over a 48-h period of time (data not
shown). Wild-type and Fermut cells were cultured in normal
and iron-free medium for 12 h and then treated with TNF for
an additional 24 h. LIP and cell viability were measured and
are shown in Fig. 5a and b. The increase in TNF-induced LIP
was only slightly less in wild-type cells under the iron-free
condition (Fig. 5a). Similar to wild-type cells, iron deprivation
did not have much effect on LIP in Fermut cells (Fig. 5a). These
data suggest that extracellular iron is not a major iron source
for TNF-induced LIP in L929 cells. Since extracellular iron
depletion does not affect the TNF-induced increase of LIP, it
is not surprising to see that TNF-induced cell death is similar
between cells in normal medium and cells in iron-free medium
(Fig. 5b). These data support our hypothesis that the major
source of iron to furnish the TNF-induced LIP is of intracel-
lular origin and that reduced iron storage in Fermut cells ac-
counts for the reduced LIP induction by TNF.
H-ferritin has a role in modulating LIP in TNF-treated
cells. It has been shown that changes in LIP in response to
extracellular stimuli are usually transitory and homeostatic in
nature (26). The substantial increase of LIP in TNF-treated
L929 cells could result from a lack of balance in regulating LIP
levels or from the possibility that the TNF-induced change
exceeds the cells’ homeostatic capacity. The latter seems un-
likely because Fermut cells that should have less homeostatic
capacity for iron are resistant to TNF-induced LIP and death.
Induction of H-ferritin and reduction of the transferrin recep-
tor are commonly used by cells to control cellular iron levels
and LIP upon treatment with different stimuli including cyto-
kines. Since the data shown in Fig. 5 indicate that the uptake
of iron does not play a major role in TNF-induced LIP in L929
cells, we next addressed the relationship between H-ferritin
and LIP levels. Because none of the antibodies available to us
could detect H-ferritin in L929 cells, we were unable to directly
evaluate the relationship between H-ferritin protein level and
LIP (data not shown). As it is reported that TNF can induce
H-ferritin expression at the mRNA level (37), we measured
H-ferritin mRNA in L929 cells before and after TNF stimula-
tion using real-time PCR. An A549 cell was used for compar-
ison because TNF-induced H-ferritin expression has been re-
ported in this cell line (50). As shown in Fig. 6a, TNF-induced
H-ferritin mRNA expression is observed in A549 cells but not
in L929 cells. Together with another report showing that no
change in H-ferritin at the mRNA or protein levels occurs in
TNF-treated L929 cells (59), we conclude that L929 cells do
not up-regulate H-ferritin expression in response to TNF stim-
ulation. We measured LIP levels of A549 in parallel with those
of L929 cells treated with TNF and found that LIP induction by
TNF in A549 cells was as drastic as in L929 cells during the first
6 h of treatment but was transient, declining to the basal levels
thereafter. In contrast, LIP levels in TNF-treated L929 cells
remained high after 24 h of TNF treatment (Fig. 6b). These
data suggest that H-ferritin induction is a mechanism in con-
trolling LIP levels in A549 cells and that this mechanism is
absent in L929 cells. ROS induction by TNF is seen much more
strongly in L929 cells than in A549 cells, in agreement with the
relationship between LIP and ROS (Fig. 6c).
To further examine whether H-ferritin induction can truly
function as a counteracting mechanism to regulate LIP levels,
we stably expressed H-ferritin under a TNF-inducible pro-
moter in L929 cells. The induction of H-ferritin in this cell line
after TNF treatment was detected by RT-PCR (Fig. 6d). We
next examined the effect of TNF-induced expression of H-
ferritin on TNF-induced LIP, ROS, and cell death in L929
cells. Indeed, ectopic H-ferritin expression under a TNF-in-
ducible system significantly inhibited TNF-reduced LIP, ROS,
and cell death in L929 cells (Fig. 6e through g). These results
raise a provocative possibility that it is not the preexisting
ferritin but the ferritin induced by a given stimulus that can act
as the protective chelator of induced LIP in the prevention of
cell death.
TNF-induced NF-B activation is normal in wild-type and
H-ferritin mutated L929 cells. Pham et al. recently reported
that H-ferritin is an NF-B-dependent gene and is primarily
responsible for the NF-B-mediated antiapoptosis effect (41).
Since H-ferritin is not inducible in L929 cells, we examined
whether L929 cells were defective in TNF-induced NF-B ac-
tivation using gel shift assays. As shown in Fig. 7a, TNF induces
NF-B activation in both wild-type and Fermut cells. Thus, the
lack of H-ferritin induction in L929 cells is not due to the
absence of NF-B activation upon TNF stimulation. Further-
more, we analyzed the promoter regions of mouse and human
H-ferritin and did not find any NF-B binding sites. Though we
FIG. 5. Endogenous storage iron furnishes TNF-induced LIP in L929 cells. (a) Wild-type (Wt) and Fermut cells were cultured in iron-containing
medium (Normal) or iron-free medium (Iron-free) for 8 h, followed by 24-h TNF (40 ng/ml) treatment. LIP levels were measured. (b) Viabilities
of the cells treated were determined as described for panel a.
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cannot exclude the possibility that an NF-B-like sequence(s)
differing from the consensus motif GGGANNYYCC can serve
as an NF-B binding site(s) in the H-ferritin promoter, it is
likely that NF-B-dependent H-ferritin induction is not di-
rectly driven by NF-B. Thus, the lack of TNF-induced H-
ferritin expression in L929 cells may not be related to the
signaling pathway that controls NF-B activation.
DISCUSSION
Using genetic mutagenesis, we systematically searched for
genes that play critical roles in TNF-induced L929 cell death,
a paradigm for necrotic (caspase-independent) cell death. Our
genetic screen has uncovered a number of factors in which full
complements of expression are needed for L929 cells to un-
dergo cell death in response to TNF (34, 39, 58). In this study,
we characterize a TNF-resistant line that harbors a mutation in
the H-ferritin gene. We found that a deficiency of H-ferritin
results in resistance to TNF and that reintroduction of H-
ferritin restores the sensitivity of L929 Fermut cells to respond
to TNF-induced killing. To a first approximation, this finding
contradicts a reported protective role of H-ferritin in ROS-
mediated cell death; however, further careful studies have re-
vealed the dynamic aspects of ferritin function in controlling
the pool of labile iron: H-ferritin can both positively and neg-
atively influence the level of LIP induction by a given stimulus.
Low, steady levels of ferritin result in less iron storage, which
in turn limits LIP induction if intracellular storage is the major
source of iron to supply increased LIP, as is the case in L929
cells; on the other hand, high levels of ferritin newly synthe-
sized by inducible expression mechanisms sequester free iron
and thus suppress LIP induction. LIP is therefore a direct
limiting factor of ROS production, and ferritin exerts its role
on ROS-mediated cell death by controlling cellular levels of
LIP. Nevertheless, it is important to note that LIP can also be
furnished by extracellular iron in some cell systems and that
FIG. 6. Induction of H-ferritin by TNF is absent in L929 cells, and ectopically introducing TNF-inducible H-ferritin inhibits TNF-induced LIP,
ROS, and cell death. (a) L929 and A549 cells were treated with TNF (100 ng/ml) for different periods of time. H-ferritin mRNA levels were
measured by real-time PCR. (b) LIP levels of the cells treated were as described for panel a. (c) ROS production in the cells treated were as
described for panel a. (d) Stable lines of L929 cells transfected with H-ferritin in a TNF-inducible expression vector (TI H-ferritin) or empty vector
(Vector) were treated with TNF for different periods of time. H-ferritin mRNA levels were examined by semiquantitative PCR. (e) LIP levels in
TI H-ferritin- and vector-transfected L929 cells after TNF treatment of different periods of time. wt, wild type. (f) ROS levels in the cells were as
described for panel e. (g) Viability of the cells was as described for panel e.
FIG. 7. (a) DNA binding activity to NF-B. Wild-type (Wt) and
Fermut L929 cells were treated with TNF for 0, 10, and 30 min. Nuclear
extracts were prepared and analyzed by gel shift assay. The autoradio-
graph is shown. (b) Proposed model of how H-ferritin regulates LIP
and the central role of LIP in TNF-induced ROS production and
ROS-dependent cell death.
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proteins involved in iron import and export can also affect LIP
and thus ROS-mediated cell death (12, 29, 30). For example,
apoptotic death of bovine aortic endothelial cells after expo-
sure to doxorubicin (DOX), a widely used anticancer drug that
induces ROS, oxidative damage, and apoptosis, is accompa-
nied by a significant increase in the transferrin-receptor-de-
pendent iron uptake (30). Together with data from previous
studies, we propose a model shown in Fig. 7 to suggest that
cellular ferritin controls LIP levels that in turn play a central
role in regulating ROS-mediated cell death.
LIP is needed for the normal metabolism of cells (26). Be-
cause of the toxicity of free iron, multiple regulatory mecha-
nisms have been invoked in cells to maintain LIP levels in a
safe range (26). Within the safe range, higher, steady levels of
LIP in the cell lead to a higher sensitivity to oxidative stress-
induced death (2, 14), as in the case of the H-ferritin-deficient
cells (Fig. 2). The protective role of higher basal levels of
H-ferritin in cell death is best demonstrated in cells that di-
rectly encountered oxidative insults (14) and can be inter-
preted as lower, steady LIP levels in the cell-limited oxidation-
mediated damage. However, higher basal levels of H-ferritin
cannot prevent LIP induction, most likely due to the possibility
that existing ferritin molecules are already occupied by iron.
Inducible expression of H-ferritin is an effective replenishing
mechanism to suppress LIP induction (Fig. 7).
RIP1 is known to be required for TNF-induced caspase-
independent cell death (23, 35). We checked if RIP1 is re-
quired for the induction of LIP in TNF-treated cells and found
that TNF cannot induce an increase of LIP in RIP1 knockout
mouse embryonic fibroblast cells (data not shown), indicating
that RIP1 is upstream of LIP induction. Our data suggest that
in L929 cells, the iron source used to supply TNF-induced LIP
is released from existing ferritin complexes. Degradation of
ferritin by the lysosome is known to be a mechanism for the
recycling of ferritin-bound iron (43). Thus, lysosomes are likely
to have a role in LIP up-regulation in TNF-treated L929 cells.
The involvement of lysosomes in TNF-induced cell death has
in fact been demonstrated by genetic and biochemical evidence
(13, 21, 22, 24, 39, 45). Degradation of ferritin may provide one
of the mechanisms of how lysosomes contribute to TNF-in-
duced cell death. Increased LIP in TNF-treated cells may func-
tion to increase iron availability for many TNF-induced cellu-
lar reactions, including enhancing the respiration chain and
other sites that could result in a notable increase of ROS
generation. TNF can induce H-ferritin expression in many
different types of cells, which may serve to limit LIP induction
and therefore control ROS. In contrast, L929 cells cannot be
induced by TNF to elevate ferritin expression and hence lack
the mechanism to limit LIP formation when exposed to TNF
and may be one of the reasons why substantial ROS are pro-
duced and cell death occurs in L929 cells (Fig. 7).
A number of studies have used iron loads and iron chelators
to address the relationship between iron and cell death (20,
25). While many cell lines are not affected in viability by acute
iron loads or iron deprivation, some cell lines can be killed by
iron deprivation (25). It is possible that different cells adopt
different means to store and reuse iron. Iron deprivation in
cells that have low iron storage or are inefficient in the recy-
cling of storage iron may quickly affect cellular metabolisms
and then trigger apoptosis. As for the cells with viability unaf-
fected by iron load or deprivation alone, preexposure of iron
load in cells can either enhance or inhibit TNF-induced cell
death. Different cells may have different abilities to adjust LIP
levels, which can be explained by the observations that iron
loads can induce ferritin expression in some cells whereas iron
treatment has no effect on ferritin expression in other cells.
LIP induction by TNF should be suppressed if the expression
of ferritin is induced by preexposure of iron, and LIP induction
should be enhanced if cells that cannot be induced express
ferritin by iron load. While this paper was in preparation,
Pham et al. reported that H-ferritin up-regulation by NF-B
inhibits TNF-induced apoptosis through suppressing ROS
(41), which is consistent with our finding that induced H-
ferritin counteracts ROS induction. Our data further show that
H-ferritin, through LIP, controls ROS levels. The work by
Pham et al. and us demonstrates that iron metabolism is in-
volved in both apoptotic and necrotic cell death. However, it is
unclear at the present time how ROS functions in apoptosis
and necrosis. ROS is believed to be upstream of caspases in the
apoptotic program (41); however, we also observed that the
inhibition of caspases equally enhances TNF-induced necrosis
in wild-type and Fermut L929 cells (Fig. 2b), suggesting that
LIP and its controlled ROS must function either unrelated or
antagonistic to caspase activity in necrosis. Nevertheless, the
role of LIP in the control of ROS appears to be the same.
Taken together, our current study has provided compelling
evidence that it is the inducibility of ferritin rather than the
absolute ferritin concentration in the cell that controls levels of
stimulus-induced LIP and that LIP is a central controller of
TNF-induced ROS and ROS-dependent cell death.
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